Thrombosis in women: what are the knowledge gaps in 2013? (Q38117735)

29 August 2017

title

Thrombosis in women: what are the knowledge gaps in 2013? (English)

1 reference

29 August 2017

0 references

knowledge gap hypothesis

1 reference

1 reference

S Middeldorp

1

1 reference

29 August 2017

publication date

1 June 2013

1 reference

Journal of Thrombosis and Haemostasis

29 August 2017

published in

1 reference

29 August 2017

volume

11 Suppl 1

1 reference

29 August 2017

page(s)

180-191

1 reference

Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies

29 August 2017

cites work

1 reference

A prospective study of the incidence of deep-vein thrombosis within a defined urban population

21 January 2018

1 reference

Oral contraceptives and the risk of venous thrombosis

21 January 2018

1 reference

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

21 January 2018

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

21 January 2018

1 reference

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

21 January 2018

1 reference

Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.

21 January 2018

1 reference

Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis.

21 January 2018

1 reference

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

21 January 2018

1 reference

Thrombophilia and venous thromboembolism: implications for testing

21 January 2018

1 reference

Evidence-based approach to thrombophilia testing

21 January 2018

1 reference

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.

21 January 2018

1 reference

Thrombophilia, clinical factors, and recurrent venous thrombotic events

21 January 2018

1 reference

Recurrence of Venous Thromtoembolic Disease and Use of Oral Contraceptives

21 January 2018

1 reference

The risk of recurrent venous thromboembolism in men and women

21 January 2018

1 reference

Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study

21 January 2018

1 reference

Hormone therapy and recurrence of venous thromboembolism among postmenopausal women

21 January 2018

1 reference

Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality

21 January 2018

1 reference

Long-term impact of pregnancy-related venous thrombosis on quality-of-life, general health and functioning: results of a cross-sectional, case-control study

21 January 2018

1 reference

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study

21 January 2018

1 reference

Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study

21 January 2018

1 reference

Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation.

21 January 2018

1 reference

Predicting deep venous thrombosis in pregnancy: out in "LEFt" field?

21 January 2018

1 reference

Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review

21 January 2018

1 reference

Anatomic distribution of deep vein thrombosis in pregnancy

21 January 2018

1 reference

Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging.

21 January 2018

1 reference

Diagnosing pulmonary embolism in pregnancy: rationalizing fetal radiation exposure in radiological procedures.

21 January 2018

1 reference

Radiation dose to the female breast from 16-MDCT body protocols.

21 January 2018

1 reference

An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy.

21 January 2018

1 reference

Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes.

21 January 2018

1 reference

Pulmonary embolism during pregnancy: diagnosis with lung scintigraphy or CT angiography?

21 January 2018

1 reference

Perfusion scintigraphy: diagnostic utility in pregnant women with suspected pulmonary embolic disease

21 January 2018

1 reference

Pulmonary Embolism in Pregnancy: CT Pulmonary Angiography Versus Perfusion Scanning

21 January 2018

1 reference

Pulmonary embolism in pregnancy: comparison of pulmonary CT angiography and lung scintigraphy

21 January 2018

1 reference

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?

21 January 2018

1 reference

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

21 January 2018

1 reference

How I treat pregnancy-related venous thromboembolism

21 January 2018

1 reference

The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey.

21 January 2018

1 reference

Antenatal pulmonary embolism: risk factors, management and outcomes

21 January 2018

1 reference

Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition).

21 January 2018

1 reference

Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.

21 January 2018

1 reference

Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.

21 January 2018

1 reference

Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis

21 January 2018

1 reference

Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?

21 January 2018

1 reference

Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism

21 January 2018

1 reference

The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy.

21 January 2018

1 reference

Thrombophilia and pregnancy complications: cause or association?

21 January 2018

1 reference

Inherited thrombophilia and pregnancy complications revisited.

21 January 2018

1 reference

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study

21 January 2018

1 reference

Increased fetal loss in women with heritable thrombophilia.

21 January 2018

1 reference

Increased risk for fetal loss in carriers of the factor V Leiden mutation

21 January 2018

1 reference

Thrombophilic disorders and fetal loss: a meta-analysis

21 January 2018

1 reference

The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies

21 January 2018

1 reference

Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies

21 January 2018

1 reference

Low-molecular-weight heparins have no place in recurrent miscarriage: debate--for the motion

21 January 2018

1 reference

SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.

21 January 2018

1 reference

Aspirin plus heparin or aspirin alone in women with recurrent miscarriage

21 January 2018

1 reference

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder

21 January 2018

1 reference

Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome

21 January 2018

1 reference

Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women

21 January 2018

1 reference

Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

21 January 2018

1 reference

Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial

21 January 2018

1 reference

Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial

21 January 2018

1 reference

Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.

21 January 2018

1 reference

Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial

21 January 2018

1 reference

Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol

21 January 2018

1 reference

Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users

21 January 2018

1 reference

The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device

21 January 2018

1 reference

Hormonal contraception and risk of venous thromboembolism: national follow-up study

21 January 2018

1 reference

World distribution of factor V Leiden

21 January 2018

1 reference

Prevalence of antithrombin deficiency in the healthy population.

21 January 2018

1 reference

Absence of thrombosis in subjects with heterozygous protein C deficiency

21 January 2018

1 reference

A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation.

21 January 2018

1 reference

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

21 January 2018

1 reference

Risk of idiopathic venous thromboembolism in users of progestagens alone

21 January 2018

1 reference

Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JTH.12266

1 reference

29 August 2017

1 reference